Noccarc raises USD 2 million from IAN, others
Advertisement
New Delhi: Noccarc, an innovative medical devices startup, has successfully raised $2 million in a recent funding round led by Indian Angel Network (IAN). The round also witnessed participation from prestigious institutions such as IIT Kanpur, SIDBI (Small Industries Development Bank of India), and TDB (Technology Development Board). Furthermore, the funding round welcomed Mr.
Sunil Munjal, the Chairman of Hero Enterprises, as a notable investor. Noccarc specializes in developing and manufacturing high value critical care medical equipment, including ICU Ventilators, Patient Monitors, and more. Additionally, the company offers a digital platform empowering doctors to access device data remotely, digitize records, and plans to integrate AI- based services in the future. The company has a strong R&D unit and has plans to develop a diverse range of products, starting with critical care. Noccarc currently holds seven patents, with 19 additional patents filed for its technologies.
The company has also recently obtained a license from CDSCO (Central Drug Standard Control Organization) which authorizes them to manufacturing and sell these regulated products in India.
The $2 million investment will be instrumental in accelerating Noccarc's growth and expanding its product portfolio. The funding round is expected to fuel research and development initiatives, facilitate market penetration, strengthen customer support, and setup a robust sales and distribution network across major cities.
"With a track record of supplying over 3,600 ventilators across India and collaborating with a diverse array of hospitals, Noccarc is now expanding its product portfolio with a vision of going global, leveraging technology, capitalizing on the China+1 tailwinds and government incentives for domestic manufacturers," the release stated.
Harshit Rathore, Co-Founder & CTO, said, “The Indian medical devices market is approx. $12 Bn, and is expected to grow to $50 Bn by 2030. Currently, 80% of the medical devices in India are imported. A key barrier for Indian Medical Devices companies in achieving domestic and global success has been the absence of IP-based products, lack of R&D, non-adherence to global quality standards, and performance metrics necessary for international approvals like the FDA and EU MDR. From day 1, we have been committed to building products that are in line with these global standards, setting the stage for a strong presence in the worldwide market. We strongly believe that delivering high-quality, world-class products at the right price, will unlock a vast market opportunity for us.”
Padmaja Ruparel, Co-Founder of Indian Angel Network, said "Noccarc has demonstrated a remarkable ability to innovate in the healthcare sector. With installations at 650+ hospitals, they are now scaling to not only to expand their client base but also to build a portfolio of smart ICU focused devices: leveraging the internet, for both patients and health care providers.”
Founders Nikhil, Harshit and Tushar, graduates of IIT Kanpur, harbored a grand vision: the creation of a global MedTech brand and India's answer to Siemens. What began as a mission to provide indigenous ICU ventilators during the first wave of the pandemic has evolved into a trajectory toward global leadership in the medical devices industry.
Read also: Fireside Ventures leads funding round of Rs 50 crore in Amaha
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.